Patent intelligence · US
US 7947720
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
Patent details — US 7947720
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 24, 2011
- Expiration
- May 19, 2031
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Claims
- 4
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P1/16
Quick answer
US 7947720 (3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands) is held by Pharmacopeia Drug Discovery, Inc.. Status: granted. Granted May 24, 2011. Expires May 19, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Expiration
- Claims
- 4
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18, A61P11/00
More from Pharmacopeia Drug Discovery, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted -
US 12420085
Synergistic therapies for inter vertebral disc degeneration
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12403069
Adapter for use in a planetary mixer
granted -
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted -
US 12396924
Adapter for use in a planetary mixer
granted
Frequently asked questions
What is US patent 7947720?
US 7947720 (3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands) is held by Pharmacopeia Drug Discovery, Inc.. Status: granted. Granted May 24, 2011. Expires May 19, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7947720?
Pharmacopeia Drug Discovery, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.
When does US 7947720 expire?
Our index shows an expiration date of May 19, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.